Coronavirus Notebook: WHO Accelerator Project Languishes, Novel Treatments Are Explored, Gilead Submits US Remdesivir Filing

 
• By Ian Schofield

Gilead files for US approval of remdesivir and boosts investment in manufacturing capacity, more funding is needed for the global ACT Accelerator initiative, and the US and China are rated among the worst responders to the COVID-19 pandemic. 

Coronavirus_Update
Efforts continue to find treatments and vaccines for COVID-19 • Source: Shutterstock

More from International

More from Geography